1st Quarter - Report

AVENUE SOLUTIONS for EXPRESS SCRIPTS INC

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007 HR 2606 340B Program Improvement and Integrity Act of 2007 HR 2914 Medicare IVIG Access Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 HR 4296 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 Competitive Bidding Contract Disclosure Regulations Comparative Effectiveness 340B Program

LobbyistCovered position, as disclosed
TRACY SPICER —
LAURIE SULLIVAN —
AMY TEJRAL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1474 (110th), H.R. 2606 (110th), H.R. 4296 (110th), H.R. 3932 (110th), H.R. 2914 (110th), H.R. 2567 (110th)

Pharmacy PHA

HR 971 Community Pharmacy Fairness Act of 2007 HR 2970 Pharmacy Benefit Manager Transparency Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1827 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 S 1954 Pharmacy Access Improvement (PhAIm) Act of 2007 S 2013 Patient and Pharmacy Protection Act of 2007 S 2085 Patient and Pharmacy Protection Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007 Internet Pharmacies Off-Label Use of Prescription Drugs.

LobbyistCovered position, as disclosed
TRACY SPICER —
LAURIE SULLIVAN —
AMY TEJRAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3090 (110th), H.R. 3193 (110th), H.R. 971 (110th), H.R. 3140 (110th), H.R. 2970 (110th)

Health Issues HCR

HR 380 Pharmaceutical Market Access and Drug Safety Act of 2007 HR 493 Genetic Information Nondiscrimination Act of 2007 HR 1368 Personalized Health Information Act of 2007 HR 1432 Preserve Access to Affordable Generics Act HR 1666 Health Care Price Transparency Promotion Act of 2007 HR 1902 Protecting Consumer Access to Generic Drugs Act of HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 3800 Promoting Health Information Technology Act H.R. 5629 Pathway for Biosimilars Act S 28 Generics First Act of 2007 S 242 Pharmaceutical Market Access and Drug Safety Act of 2007 S 251 Pharmaceutical Market Access Act of 2007 S 273 Prescription Drug and Health Improvement Act of 2007 S 316 Preserve Access to Affordable Generics Act S 358 Genetic Information Nondiscrimination Act of 2007 S 596 Safe Internet Pharmacy Act of 2007 S 628 Critical Access to Health Information Technology Act of 2007 S 976 Genomics and Personalized Medicine Act of 2007 S 1408 Health Information Technology Act of 2007 S 1455 National Health Information Technology and Privacy Advancement Act of 2007 S 1505 Affordable Biologics for Consumers Act S 1693 Wired for Health Care Quality Act S 1695 Biologics Price Competition and Innovation Act of 2007 S. 1814 Health Information Privacy and Security Act S 2408 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Health Information Technology Electronic Prescribing Genetic Nondiscrimination Inappropriate use of Human Growth Hormone Confidentiality of Health Information Generic Drugs Generic Biologics

LobbyistCovered position, as disclosed
TRACY SPICER —
LAURIE SULLIVAN —
AMY TEJRAL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 493 (110th), S. 1814 (110th), H.R. 5629 (110th), H.R. 1902 (110th), H.R. 3800 (110th), H.R. 1432 (110th), H.R. 1666 (110th), H.R. 1956 (110th), H.R. 380 (110th), H.R. 1368 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.